Disease/Infection News

RSS

Monkeypox virus infection and its persistence in the testes of infected crab-eating macaques

Researchers performed retrospective detection of the monkeypox virus in the testes of nonhuman primates.

22 Oct 2022

Anthelmintic inhibits exacerbated inflammatory response related to COVID-19 in preclinical research

Experiments involving animals and human cells conducted at the University of São Paulo (USP) in Brazil suggest that niclosamide, an anthelmintic widely used against tapeworms, effectively inhibits SARS-CoV-2 replication as well as the exacerbated inflammatory response that leads to death in many patients with severe COVID-19.

21 Oct 2022

Clinical-pathological links between SARS-CoV-2 placentitis, stillbirth and maternal COVID-19 vaccination

Drucilla J. Roberts, MD, from the Mass General Department of Pathology and colleagues recently published a literature review in the American Journal of Obstetrics & Gynecology, titled SARS-CoV-2 Placentitis, Stillbirth and Maternal COVID-19 Vaccination: Clinical-Pathological Correlations.

21 Oct 2022

Modeling study suggests the possibility of Japanese encephalitis virus outbreak in Australia

A paper from a research team, which included mathematical modeling expertise from LSHTM and was led by the QIMR Berghofer Medical Research Institute in Brisbane, has suggested that up to 750,000 people across Australia could be at risk of exposure to Japanese encephalitis (JEV).

21 Oct 2022

Adaptive immune responses in adults of various ages receiving 2 doses of the BNT162b2 mRNA vaccine

Researchers assessed the correlation between immunosenescence and poor COVID-19 vaccination outcomes in older adults.

21 Oct 2022

Exploring SARS-CoV-2-associated endothelial dysfunction

A new study described the evidence, mechanisms, and therapies for endothelial dysfunction in coronavirus disease 2019 (COVID-19).

21 Oct 2022

Three-dose regimen of HEPLISAV-B vaccine fully protects people living with HIV, data shows

The AIDS Clinical Trials Group (ACTG), the world's largest HIV research network whose focus has expanded to include evaluating outpatient treatment for COVID-19, today presented a session demonstrating that a three-dose regimen of the HEPLISAV-B vaccine fully protected people living with HIV at IDWeek 2022, taking place in Washington D.C. from October 19-22, 2022.

20 Oct 2022

Scientists develop human salivary gland organoids to test SARS-CoV-2 infectivity

In a recent study published in the journal Nature Cell Biology, researchers demonstrated the susceptibility of salivary glands to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in vitro using an organoid culture model.

20 Oct 2022

Analgesic use after COVID-19 vaccination does not negatively affect antibody responses

In a recent study posted to the medRxiv* preprint server, University of Arizona researchers assessed the relationship between antibody responses and analgesic usage after coronavirus disease 2019 (COVID-19) vaccination.

20 Oct 2022

Multiomics analysis identifies immunobiomarkers for COVID-19 severity in outpatients

In a recent study published in the journal eLife, researchers showed the utility of machine-learning models in identifying early immune signatures, which could reliably predict clinical and immunological outcomes in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-infected outpatients.

20 Oct 2022

Regenstrief Institute and Indiana Department of Health partner on an influenza surveillance data pilot study

Regenstrief Institute and the Indiana Department of Health are collaborating on an influenza surveillance data pilot study to provide in-depth data and analysis of the spread of Influenza in Indiana, similar to how Regenstrief has provided data on COVID-19.

20 Oct 2022

Are pediatric COVID-19 samples less infectious?

Researchers determine whether children are less hospitable to SARS-CoV-2 and, as a result, pose a lower risk of a viral spread than adults.

20 Oct 2022

Three-dose course of the hepatitis B vaccine fully protects adults living with HIV

A three-dose course of the hepatitis B vaccine HEPLISAV-B fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to study findings presented today at the IDWeek conference in Washington, D.C.

20 Oct 2022

Disease/Infection News

Monkeypox virus infection and its persistence in the testes of infected crab-eating macaques

Anthelmintic inhibits exacerbated inflammatory response related to COVID-19 in preclinical research

Clinical-pathological links between SARS-CoV-2 placentitis, stillbirth and maternal COVID-19 vaccination

Modeling study suggests the possibility of Japanese encephalitis virus outbreak in Australia

Adaptive immune responses in adults of various ages receiving 2 doses of the BNT162b2 mRNA vaccine

Exploring SARS-CoV-2-associated endothelial dysfunction

Three-dose regimen of HEPLISAV-B vaccine fully protects people living with HIV, data shows

Scientists develop human salivary gland organoids to test SARS-CoV-2 infectivity

Analgesic use after COVID-19 vaccination does not negatively affect antibody responses

Multiomics analysis identifies immunobiomarkers for COVID-19 severity in outpatients

Regenstrief Institute and Indiana Department of Health partner on an influenza surveillance data pilot study

Are pediatric COVID-19 samples less infectious?

Three-dose course of the hepatitis B vaccine fully protects adults living with HIV

Racial, ethnic disparities found in flu vaccination coverage and hospitalization rates

New method opens path for targeting the molecules responsible for HIV virus' growth

Review of characteristics of human monkeypox

What are the complications, preventative measures, and treatments of ocular monkeypox?

CDC advises on monkeypox sample collection protocols after U.S. exposure case

UK hospital study explores whether monkeypox can be transmitted through aerosolized droplets and fomites

Breakthrough infection risk and immune responses to vaccines associated with human leukocyte antigen alleles

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News